# FDA Inspection 841845 - Baxter R & D Europe SPRL - June 21, 2013

Source: https://www.keypedia.com/records/fda_inspections/baxter-r-d-europe-sprl/3a6091a8-b36b-42a7-acb4-0b0676047712
Source feed: FDA_Inspections

> FDA Inspection 841845 for Baxter R & D Europe SPRL on June 21, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 841845
- Company Name: Baxter R & D Europe SPRL
- Inspection Date: 2013-06-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1207395 - 2023-02-02](https://www.keypedia.com/records/fda_inspections/baxter-r-d-europe-sprl/ffe32747-22e4-46de-a309-d33fba4e7cec)
- [FDA Inspection 841845 - 2013-06-21](https://www.keypedia.com/records/fda_inspections/baxter-r-d-europe-sprl/35e782a4-fb6f-48b3-9a8b-2ca5e9d089a1)

Company: https://www.keypedia.com/companies/baxter-r-d-europe-sprl/ffef6a40-5330-4e2f-9f17-a6a3089f963e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d